|
Real-time Estimate
Cboe BZX
10:16:24 2026-04-13 am EDT
|
5-day change
|
1st Jan Change
|
|
32.19 USD
|
+3.84%
|
 |
+3.27%
|
+2.49%
|
|
Mar. 16 |
Mbx Biosciences Insider Bought Shares Worth $525,663, According to a Recent SEC Filing
|
MT
| |
Mar. 10 |
MBX Biosciences, Inc. Appoints Karen Basbaum As Chief Business Officer
|
CI
| |
Feb. 27 |
MBX Biosciences Says CFO to Step Down; Names Interim Finance Chief
|
MT
| |
Feb. 27 |
MBX Biosciences, Inc. Announces CFO Changes
|
CI
| |
Jan. 22 |
MBX Biosciences, Inc. Announces Board and Committee Changes
|
CI
| |
Nov. 06 |
Mbx Biosciences, Inc. Announces Changes to Its Board, Effective from October 31, 2025
|
CI
| |
Nov. 06 |
Mbx Biosciences, Inc. Appoints Steve Hoerter to Serve as Executive Chairperson, Effective from November 6, 2025
|
CI
| |
25-10-21 |
Mbx Biosciences Insider Bought Shares Worth $272,790, According to a Recent SEC Filing
|
MT
| |
25-06-23 |
MBX Biosciences, Inc Appoints Andreas Moraitis as Senior Vice President of Clinical Development
|
CI
| |
25-06-06 |
MBX Biosciences, Inc. Announces Departure of Carl L. Gordon from the Company's Board of Directors, Effective June 5, 2025
|
CI
| |
25-04-07 |
MBX Biosciences, Inc. Announces the Appointment of Steve Hoerter as an Independent Director, Effective April 7, 2025
|
CI
| |
25-03-05 |
MBX Biosciences Announces Additions To Leadership Team
|
RE
| |
25-03-05 |
MBX Biosciences, Inc. Announces Management Appointments
|
CI
|
No results for this search Select your edition All financial news and data tailored to specific country editions | 
